UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
June 20, 2014
Date of Report (Date of earliest event reported)
 
SPOTLIGHT INNOVATION INC.
(Exact name of registrant as specified in its charter)
 
Nevada
 
333-141060
 
98-0518266
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)

6750 Westown Parkway, Suite 200-226
West Des Moines, IA
 
50266
(Address of principal executive offices)
 
(Zip Code)

(515) 274-9087
Registrant’s telephone number, including area code

N/A
 (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 

 
 
Item 5.02 Departure Of Directors Or Principal Officers; Election Of Directors; Appointment Of Principal Officers
 
Effective June 20, 2014 David Hostelley was named Chief Financial Officer of Spotlight Innovation Inc. (the “Company”). The Company entered into an agreement with Dr. Hostelley whereby Mr. Hostelley would serve as Chief Financial Officer of the Company for six months, and receive a salary of $4,000 per month. A copy of this Agreement is annexed as an exhibit hereto.

Dr. Hostelley, is a CPA(inactive) licensed by the state of Ohio. He earned his Ph.D. in management while a lecturer in the MBA Program of Baldwin-Wallace College. He formerly lectured in Accounting and Management for Walsh University, North Canton, Ohio. For the past five years to the present he has served as CEO/CFO and board member of publicly traded companies, which are:

From 08-09 to 01-11 EARI.PK / Entertainment Arts Research, Inc.
From 06-10 to 07-11 QEBR.OB / Virtual Medical International, Inc.
From 03-11 to 9-11CVSL.OB / Cardio Vascular Medical Device, Inc.

Dr. Hostelley spent 20 years as a consultant in the Health field. He has structured numerous acquisitions in the fields of printing, oil and gas development, private schools, insurance agencies, hotels, manufacturing, debit card issuance, health products and health clubs and service entities. He has formed Not-For-Profit entities and serves on the board of trustees. In his capacity of trainer in the field of Project Management, Dr. Hostelley has taught the executives of many companies including but not limited to: Ford Motor Company, Westinghouse, National Fuel Gas, General Electric, Stromberg-Carlson, Doehler-Jarvis, Marvin Windows, Progressive Insurance, EDI Engineering, Sun Exploration, Tennessee Valley Authority, SPX Corporation, The Venezuelan Oil Ministry, Ford Museum in Greenfield Village. He has lectured in South Africa, Venezuela, Canada, and the United States.
 
Item 9.01 Financial Statements and Exhibits
 
(d) Exhibits.
 
Exhibit No.
 
Description
 
Filed with this
Current Report
 
Incorporated by reference
 
 
 
 
 
 
Form
 
Filing Date
 
Exhibit No.
10.9
 
Agreement between Spotlight Innovation Inc. and David Hostelley dated June 20, 2014.
 
x
           
                     
99.1   Press Release dated June 23, 2014.   x            
 
 
2

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  SPOTLIGHT INNOVATION INC.  
       
Date: June 24, 2014
By:
/s/ Cristopher Grunewald  
    Name: Cristopher Grunewald  
    Title: President  
 
 
3



EXHIBIT 10.9
 
 
 
1

 
 
 
2

 
 

 
3

 



 
4

 



EXHIBIT 99.1
 
Spotlight Innovation names Dr. David Hostelley Chief Financial Officer
 
FOR IMMEDIATE RELEASE – June 24, 2014, West Des Moines, Iowa.

Spotlight Innovation, Inc. (OTCQB:STLT) today announced that effective June 20, 2014, Dr. David Hostelley has been named Chief Financial Officer of the Company. Dr. Hostelley has spent twenty years as a consultant in the health field. He has structured numerous acquisitions in the fields of printing, oil and gas development, private schools, insurance agencies, hotels, manufacturing, debit card issuance, health products and health clubs, and service entities. He has formed Not-For-Profit entities and serves on the board of trustees. Dr. Hostelley is a CPA (inactive) licensed by the state of Ohio. He earned his Ph.D. in management while a lecturer in the MBA Program of Baldwin-Wallace College, and has lectured in Accounting and Management for Walsh University, North Canton, Ohio. During his more than twenty years in business he has served as CEO, CFO and board member of several publicly traded companies.

Cristopher Grunewald, President and CEO, said, “We are excited to have Dr. Hostelley on board as Chief Financial Officer. His impressive track record in the health field, considerable experience with SEC reporting companies, and commitment to Spotlight Innovation’s strategic vision make him the ideal executive for this position. We expect his contributions to play a key role in the continued growth of the Company.”

About Spotlight Innovation, Inc.

Spotlight Innovation, Inc., provides solutions for healthcare-focused companies commercializing healthcare intellectual property developed by major centers of academia in the United States. The company focuses on identifying, validating and acquiring/cooperating with early stage companies developing healthcare technologies including pharmaceuticals, devices and equipment, diagnostic products and healthcare IT. Additional information is available at www.spotlightinnovation.com.
 
Forward Looking Statements
 
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

Source: Spotlight Innovation, Inc.

 
1

 
 
Press Contact
Rene Erickson
Spotlight Innovation, Inc.
 
1-515-274-9087
corpcomm@spotlightinnovation.com

Investor Relations Contact
Mike Reysack
Spotlight Innovation, Inc.
1-641-512-1035
investor.relations@spotlightinnovation.com
 
2